pharmaceutical industry Archives

Duchenne Muscular Dystrophy — The High-Stakes Partnership: Can Elixirgen Therapeutics and Nippon Shi (featured)

The High-Stakes Partnership: Can Elixirgen Therapeutics and Nippon Shinyaku Deliver on Duchenne Muscular Dystrophy Treatment?

As the pharmaceutical industry continues to evolve, the partnership between Elixirgen Therapeutics and Nippon Shinyaku for the development of EXG-7001, a treatment for Duchenne Muscular Dystrophy

26 Jun 2026 · 10:23 GMT 3 months ago

Current Affairs

The Tight Connection: Unraveling the Mysteries of Tight Junctions

Unravel the mysteries of tight junctions, a crucial component of human health, and discover how research is leading to groundbreaking treatments for diseases like cancer and inflammatory disorders.

21 Jun 2026 · 05:28 GMT 3 months ago